Evaluation of the vascular endothelial growth factor (VEGF)-C role in urothelial carcinomas of the bladder

Anticancer Research

Volumn 26, Issue 5 A, 2006, Pages 3567-3571

  Mylona, Eleni ^a   Magkou, Christina ^a   Gorantonakis, George ^a   Giannopoulou, Ioanna ^a   Nomikos, Alexandros ^a   Zarogiannos, Aristides ^a   Zervas, Anastasios ^a   Nakopoulou, Lydia ^a,b  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Bax; Bladder urothelial carcinoma; Immunohistochemistry; Ki 67; VEGF C

Indexed keywords

KI 67 ANTIGEN; PROTEIN BAX; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; AGED; AGED, 80 AND OVER; BCL-2-ASSOCIATED X PROTEIN; CYTOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 33750695256     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N and Alitalo K: A novel vascular endothelial growth , VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Embo J 15: 290-298, 1996.
2. McColl BK, Stacker SA and Achen MG: Molecular regulation of the VEGF family - inducers of angiogenesis and lymphangiogenesis. APMIS 112: 463-480, 2004.
3. Witte D, Thomas A, Ali N, Carlson N and Younes M: Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma. Cancer Res 22: 1463-1466, 2002.
4. Gunningham SP, Currie MJ, Han C, Robinson BA, Scott PA, Harris AL and Fox SB: The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Clin Cancer Res 6: 4278-4286, 2000.
5. Vacca A, Ria R, Ribatti D, Semerado F, Djonov V, Di Raimondo F and Dammacco F: A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma. Haematologica/J Hematol 88: 176-185, 2003.
6. Ichikura T, Tomimatsu S, Ohkura E and Mochizuki H: Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma. J Surg Oncol 78: 132-137, 2001.
7. Onogawa S, Kitadai Y, Tanaka S, Kuwai T, Kimura T and Chayama K: Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastases and prognosis of patient colorectal carcinoma. Cancer Sci 95: 32-39, 2004.
8. Kajita T, Ohta Y, Kimura K, Tamura M, Yanaka Y, Tsunezuka Y, Oda M, Sasaki T and Watanabe G: The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer 85: 255-260, 2001.
9. Kinoshita J, Kitamura K, Kabashima A, Saeki H, Tanaka S and Sugimachi K: Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer Res Treat 66: 159-164, 2001.
10. Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Tsukiyama A, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I and Kakudo K: Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up. Mod Pathol 16: 309-314, 2003.
11. Nishida N,Yano H, Komai K, Nishida T, Kamura T and Kojiro M: Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma. Cancer 101: 1364-1374, 2004.
12. Kurahara H, Takao S, Maemura K, Shinchi H, Natsugoe S and Aikou T: Impact of vascular endothelial growth factor-C and - D expression in human pancreatic cancer: Its relationship to lymph node metastasis. Clin Cancer Res 10: 8413-8420, 2004.
13. Suzuki K, Morita T and Tokue A: Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder. Int J Urol 12: 152-158, 2005.
14. Miyata Y, Kanda S, Ohba K, Nomata K, Hayashida Y, Eguchi J, Hayashi T and Kanetake H: Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C and -D. Clin Cancer Res 12: 800-806, 2006.
15. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds.). Tumors of the Urinary System and Male Genital Organs, World Health Organization. Classification of Tumors. Pathology and Genetics. IARC Press, Lyon, 2004.
16. Giannopoulou I, Nakopoulou L, Zervas A, Lazaris AC, Stravodimos K, Giannopoulos A and Davaris P: Immunohistochemical study of pro-apoptotic factors Bax, Fas and CPP32 in urinary bladder cancer: prognostic implications. Urol Res 30: 342-345, 2002.
17. Nakopoulou L, Vourlakou C, Zervas A, Tzonou A, Gakiopoulou H and Dimopoulos M-A: The prevalence of bcl-2, p53 and Ki67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. Hum Pathol 29: 146-154, 1998.
18. Jia YT, Li ZX, He YT, Liang W, Yang HC and Ma HJ: Expression of vascular endothelial growth factor-C and the relationship between lymphangiogenesis and lymphatic metastasis in colorectal cancer. World J Gastroenterol 10: 3261-3263, 2004.
19. Tanigaki Y, Nagashima Y, Kitamura Y, Matsuda H, Mikami Y and Tsukuda T: The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma. Int J Mol Med 14: 389-395, 2004.
20. Gunningham SP, Currie MJ, Han C, Robinson BA, Scott PA, Harris AL and Fox SB: The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Clin Cancer Res 6: 4278-4286, 2000.
21. Kitadai Y, Amioka T, Haruma K, Tanaka S, Yoshihara M, Sumii K, Matsutani N, Yasui W and Chayama K: Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer 93: 662-666, 2001.
22. Zhou Y, Bellingard V, Feng K-T, McMaster M and Fisher S: Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang2, PIGF, and VEGF-C. Developmental Biology 263: 114-125, 2003.